Study
Curcumin May Ease Knee Arthritis Pain with Fewer Side Effects
Curcumin was found to be as effective as diclofenac in reducing knee osteoarthritis pain but with fewer gastrointestinal issues.
Summary
In plain language
A recent study explored the effects of curcumin, a compound found in turmeric, compared to the common anti-inflammatory drug diclofenac for treating knee osteoarthritis. Researchers discovered that curcumin provided similar pain relief as diclofenac. However, it had fewer side effects, particularly related to stomach issues. This is important for older adults who are often at risk for gastrointestinal problems with standard arthritis medications. Curcumin also showed additional benefits like reducing bloating and helping with weight management. If you're considering alternative treatments for arthritis, it might be worth discussing curcumin with your healthcare provider.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
The study was a randomized, open-label trial involving 139 patients with knee osteoarthritis. Participants received either curcumin capsules or diclofenac tablets daily for 28 days.
Curcumin and diclofenac provided similar pain relief, but curcumin caused fewer stomach issues, with only 13% experiencing side effects compared to 38% with diclofenac.
Curcumin also helped reduce bloating and supported weight loss, showing additional health benefits.
While curcumin appears promising, its long-term effects were not studied, and its availability in the bloodstream is lower than other treatments.
It's advisable to consult with your healthcare provider before making any changes to your arthritis treatment plan.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Curcumin May Ease Knee Arthritis Pain with Fewer Side Effects
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 21, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored well in study design due to its randomized controlled trial format. However, it lacked blinding, affecting bias control. Statistical methods were robust, but transparency was limited by retrospective registration. The absence of external replication and unclear journal quality also impacted the score. The study's relevance to older adults was partial, as it included a mixed-age population without specific subgroup analysis for seniors.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 3.3/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 5.0/10 | |
| Conflicts & funding | 10.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 5.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This randomized open-label trial compared the efficacy and safety of curcumin versus diclofenac in 139 patients with knee osteoarthritis. Curcumin showed similar pain relief to diclofenac but with fewer adverse effects, suggesting it as a potential alternative for patients intolerant to NSAIDs.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.